TNF-α neutralizing agents and inhibitors have being used extensively to treat inflammatory diseases such as Crohn’s disease (CD), psoriasis, psoriatic arthritis (PA), and rheumatoid arthritis (RA), which result from the excessive production of TNF-α in the body (2). This evidence concerns the gene TNF and psoriatic arthritis.